Markets › India › NSE › MOREPENLAB

Morepen Laboratories Ltd

NSE:MOREPENLABHealthcare

₹121.49−1.92%At closeAt close · Mon 19 Oct · ≈ AED 4.69 · Market cap $709.15M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	33.1%	31.2%	15.5%	36.3%	34.4%	37.8%	—	—
Operating margin	7.9%	8.1%	3.4%	24.5%	17.3%	4.9%	4.9%	+0.0 pts
Net margin	8.3%	6.6%	2.7%	5.7%	6.4%	5.3%	6.6%	+1.4 pts
EBITDA margin	11.1%	10.2%	6.0%	10.1%	10.5%	9.6%	—	—
Return on equity	22.9%	17.6%	5.1%	11.3%	10.2%	7.6%	9.6%	+2.0 pts
Return on assets	11.3%	9.5%	3.5%	7.4%	6.6%	4.9%	6.2%	+1.3 pts
Return on capital employed	20.3%	20.5%	6.1%	46.8%	24.7%	6.2%	—	—
Debt / equity	0.3×	0.2×	0.0×	0.0×	0.1×	0.2×	0.2×	−0.1%
Debt / assets	15.9%	12.4%	2.3%	2.2%	5.9%	10.7%	—	—
Interest coverage	51.7×	51.7×	24.5×	112.5×	37.9×	5.4×	—	—
Current ratio	1.3×	1.6×	2.4×	2.2×	2.3×	2.4×	2.4×	+0.0%
Quick ratio	0.9×	1.0×	1.6×	1.6×	1.7×	1.8×	—	—
Cash ratio	0.1×	0.0×	0.1×	0.0×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	1.4×	1.4×	1.3×	1.3×	1.0×	0.9×	—	—
Inventory turnover	4.5×	3.8×	4.2×	4.4×	4.0×	4.1×	—	—
Receivables turnover	6.1×	6.0×	5.3×	5.2×	5.6×	5.4×	—	—
Dividend payout	0.5%	0.0%	0.0%	0.0%	0.0%	11.4%	—	—